Patent · US Active

Human binding molecules having killing activity against enterococci

US9428572B2 · kind B2 · utility

10Cited by

15References

13Claims

0Family size

Assignee

Janssen Vaccines & Prevention B.V.

Inventors

Mark Throsby · Utrecht, NL
Robert A. Kramer · Crown Point, US
Cornelis Adriaan De Kruif · De Bilt, NL

Key dates

Filing date	Dec 10, 2013
Grant date	Aug 30, 2016
Priority date	—
Expiry date	Feb 27, 2034

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/21
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described are human binding molecules specifically binding to enterococci and having killing activity against enterococci, nucleic acid molecules encoding the human binding molecules, compositions comprising the human binding molecules and methods of identifying or producing the molecules. The molecules can be used, for example, in the diagnosis, prophylaxis, and/or treatment of a condition resulting from Enterococcus.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.